表紙
市場調查報告書
商品編碼
1034350

袖狀胃切除設備的全球市場:2021年∼2028年

Global Sleeve Gastrectomy Devices Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

袖狀胃切除術,是外科性的減重手術。由於外科性切除胃的大部分,約縮小到原來大小的15%。肥胖的發生率增加,預計帶動袖狀胃切除設備市場。

本報告提供全球袖狀胃切除設備市場相關調查分析,產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球袖狀胃切除設備市場 - 調查手法和範圍

第2章 全球袖狀胃切除設備市場 - 市場定義和概要

第3章 袖狀胃切除設備市場 - 摘要整理

第4章 全球袖狀胃切除設備市場 - 市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 機會
    • 影響分析

第5章 全球袖狀胃切除設備市場 - 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未滿足需求

第6章 全球袖狀胃切除設備市場 - COVID-19分析

  • 對市場的COVID-19分析
  • COVID-19的價格趨勢
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球袖狀胃切除設備市場:各產品類型

  • 簡介
  • 組織封閉設備
  • 解剖、定調位設備

第8章 全球袖狀胃切除設備市場:各終端用戶

  • 簡介
  • 醫院
  • ASC、肥胖中心

第9章 全球袖狀胃切除設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第10章 全球袖狀胃切除設備市場:競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品基準

第11章 全球袖狀胃切除設備市場企業簡介

  • Intutive Surgical Inc.
  • Apollo Endosurgery Inc.
  • TransEnterix Inc.
  • Cousin Biotech
  • EnteroMedics Inc.
  • Medtronics Plc.
  • Medsinglong Co Ltd.
  • Guangzhou Medunion Technologies Co.ltd
  • Guangzhou Maya Medical Equipment.Co.ltd
  • Agency for Medical Innovations等

第12章 全球袖狀胃切除設備市場:DataM

目錄
Product Code: DMMD4235

Market Overview

Sleeve gastrectomy is a surgical weight-loss procedure. By surgical removal a large portion of the stomach is reduced to about 15% of its original size along the greater curvature.

The sleeve gastrectomy devices market size was valued at US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028).

Market Dynamics

Increasing incidence of obesity and rise in demand for laparoscopic surgeries is estimated to drive the growth of market

Increasing incidence of obesity is estimated to drive the sleeve gastrectomy devices market.

In 2020, 39% of adults in the world were overweight. Globally, one in five children and adolescents are overweight. Surgical weight-loss procedure, sleeve gastrectomy is also called a vertical sleeve gastrectomy. This procedure is performed laparoscopically, through multiple small incisions it involves inserting small instruments in the upper abdomen. During sleeve gastrectomy, around 80% of the stomach is removed, leaving a tube-shaped stomach about the size and shape.

Limitation of the size of the stomach restricts the amount of food one can consume, the procedure in addition prompts hormonal changes that assist with weight loss. These hormonal changes also help relieve conditions associated with being overweight, such as high blood pressure or heart disease. Sleeve gastrectomy is done to help lose excess weight and reduce risk of potentially life-threatening weight-related health problems. This gastrectomy is done to help lose excess weight and reduce your risk of potentially life-threatening weight-related health problems. Sleeve gastrectomy is typically done only after one has tried to lose weight by improving diet and exercise habits. It is possible to lose approximately 60% or even more of excess weight within two years. Sleeve gastrectomy in addition to weight loss, may improve or resolve conditions related to being overweight, including heart disease and high blood pressure.

Rise in demand for laparoscopic surgeries is estimated to drive the market

The sleeve gastrectomy is a laparoscopic procedure. The procedure involves in the abdomen making five or six small incisions and performing it using a video camera (laparoscope) and long instruments placed through these small incisions. About 75% of the stomach is removed during the laparoscopic sleeve gastrectomy, leaving a narrow gastric"sleeve" or "tube". During the sleeve gastrectomy no intestines are removed or bypassed. The LSG takes one to two hours to complete. It is primarily used as part of a staged approach to surgical weight loss. Patients with a very high (BMI) or a longer procedure or at risk for undergoing anesthesia due to lung or heart problems may benefit from this approach. Sometimes before surgery the decision to proceed with a two-stage approach is made due to the known risk factors. In other patients during the operation the decision to perform sleeve gastrectomy (instead of gastric bypass) is made. Intraoperatively, reasons for making this decision include an extensive scar tissue or excessively large liver that makes the gastric bypass procedure too long or unsafe.

As a first stage procedure in patients who undergo LSG, the second stage is performed 12 to 18 months after weight loss has occurred significantly and the risk of anesthesia is much lower. Though this approach involves two procedures, it is believed that it is effective and safe for selected patients. LSG can also be used as a primary procedure. There is relatively less data regarding the use of laparoscopic sleeve gastrectomy as a stand-alone procedure in patients with lower BMI.

Drawbacks related to sleeve gastrectomy is estimated to hamper the sleeve gastrectomy devices market

Bleeding, leakage and gastric fistulae are the most common intraoperative complications and postoperative complications after sleeve gastrectomy. The majority of problems are focused on the post-operative effects rather than intra-operative leaks and bleeds. The methods using for detecting intra-operative staple line bleeds are not standardized. Still, they present a different challenge in which bleeds are often undocumented or considered a nuisance and are routinely treated with cauterization, sutures, sealants, and clips or might be self-resolved by the application of pressure along the staple line. Very less studies have addressed the impact of intra-operative leaks and bleed on other complications or factors such as operative time, cost, and length of stay. A variety of complications can happen in the post-operative period. The most common complications among patients during this time include pulmonary emboli, hemorrhage, chest infections, abscess, incisional hernia, laparoscopy for retained drain, anatomic leakage, wound infections, gastroesophageal reflux disease (GERD), and rhabdomyolysis in men. Also, dumping usually occurs around an hour after eating and presents with bloating, flushing, diarrhea, and light-headedness symptoms.

LDL cholesterol and total cholesterol levels were more different in males. Over the last years, some investigations have proven that women are more addicted to sweets than meat products. During reproductive ages, women are naturally susceptible to iron deficiency and anemia. Men, on the other side, tend to be heavier with larger muscle mass that may increase surgical time and general postoperative complications, including rhabdomyolysis

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry. To stop its growth, government-imposed lockdown. People are fearful they will experience negative health and occupational effects from the COVID-19 pandemic. All the manufacturing, as well as supply chains, have been hit due to the COVID-19 restrictions. Hence, the sleeve gastrectomy devices market has seen a decrease in its market.

Segment Analysis

The tissue closure devices segment is estimated to dominate the sleeve gastrectomy devices market

Novel technologies and techniques are being developed that can be used in the treatment of transmural defects. The various devices include: through-the-scope clips (TTSC), cap mounted clips, covered self-expandable metal stents (CSEMS), tissue sealants, endoscopic sutures, cardiac septal defect occluders, septotomies, balloon dilators, endoscopic internal drainage with double pigtails (EID) and endoscopic vacuum therapy (EVT). There is experience with endoscopic suturing use in the treatment of gastrointestinal closure/ leak fistula. These can be acute or chronic and often result in complications from surgical anastomoses and stapled tissue divisions such sleeve gastroplasty.

Suturing is often used in connection with other therapies including stents and glue. The StomaphyX suturing system was used to treat gastric leaks in two bariatric patients. The OverStitch device achieved closure in 3 of 7 patients with gastrogastric fistulae after gastric bypass. This device has been used for a variety of fistulae. Patients who are fortunate enough to have removal of their feeding tube after gastrostomy usually have wound closure, but occasionally there is a persistent gastrocutaneous fistula. A variety of closure techniques and endoscopic suturing may be employed as the sole intervention or in combination with other therapies.

The hospital segment is expected to dominate the sleeve gastrectomy devices market

Increased government and private funding, growing preference among physicians and patients to perform procedures in a hospital-based environment. In many developed and developing countries hospital facilities are well equipped with the latest innovative technologies. And the skilled staff in these procedures provide all the necessary facilities to carry out such treatments. For a district general hospital serving 250,000, the workload entails about 3500 procedures annually, performed during ten half-day routine sessions plus emergency work. High standards of training and experience are provided to the staff, who work to build accommodation designed to promote efficient and safe practice. A huge number of patients rely on hospitals because they engage closely with many reimbursement authorities, suppliers, and government organizations. The number of sleeve gastrectomy performed in hospitals and clinics is increasing, which will drive the sales of sleeve gastrectomy devices.

Geographical Analysis

North America region is estimated to dominate the sleeve gastrectomy devices market

The availability of technologically advanced medical facilities in North America is driving the market growth is this region. The surge in the incidences of obesity is likely to increase the demand for bariatric surgery by boosting the market of laparoscopy. Increasing number of gastrectomy procedures in North America is also expected to drive the market growth. For instance, each year, nearly 200,000 Americans have bariatric surgery. Still more than an estimated 24 million are enough to qualify for the operation and many of them are struggling with the decision to have such a radical treatment, the only one that leads to intense and lasting weight loss for virtually everyone who has it.

Competitive Landscape

Major key players in the sleeve gastrectomy devices market are Intutive Surgical Inc., Apollo Endosurgery Inc., TransEnterix Inc., Cousin Biotech, EnteroMedics Inc., Medtronics Plc., Agency for Medical Innovations, Aspire Bariatrics Inc., Mediflex Surgical Products. and Ethicon Inc.

Global Sleeve Gastrectomy Devices Market - Key Companies to Watch

Intutive Surgical Inc.

  • Overview: A global technology leader in minimally invasive care and the pioneer of robotic-assisted. The company brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings and develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system.
  • Product Portfolio: The company comprises robotics, medical devices, minimally invasive surgery, robotic-assisted surgery, robotic surgery, lung biopsy, and endoluminal system.

Why Purchase the Report?

  • Visualize the composition of the sleeve gastrectomy devices market -segmentation by product type and end-user, highlighting the key commercial assets and players.
  • Identify commercial opportunities in sleeve gastrectomy devices market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of sleeve gastrectomy devices market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global sleeve gastrectomy devices market report would provide an access to an approx. 52 market data table, 40 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Sleeve Gastrectomy Devices Market - By Product Type

  • Tissue closure devices
  • Dissection and positioning devices

Global Sleeve Gastrectomy Devices Market - By End User

  • Hospitals
  • ASCs and obesity centers

Global Sleeve Gastrectomy Devices Market - By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Sleeve Gastrectomy Devices Market - Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Sleeve Gastrectomy Devices Market - Market Definition and Overview

3. Sleeve Gastrectomy Devices Market - Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by End User
  • 3.3. Market Snippet by Region

4. Global Sleeve Gastrectomy Devices Market -Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidence of obesity is estimated to drive the sleeve gastrectomy devices market
      • 4.1.1.2. Rise in demand for laparoscopic surgeries is estimated to drive the market
    • 4.1.2. Restraints:
      • 4.1.2.1. Drawbacks related to sleeve gastrectomy is estimated to hamper the sleeve gastrectomy devices market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Sleeve Gastrectomy Devices Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Global Sleeve Gastrectomy Devices Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Sleeve Gastrectomy Devices Market - By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Tissue closure devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Dissection and positioning devices

8. Global Sleeve Gastrectomy Devices Market - By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 8.1.2. Market Attractiveness Index, By End User Segment
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. ASCs and Obesity Centers

9. Global Sleeve Gastrectomy Devices Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Global Sleeve Gastrectomy Devices Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Global Sleeve Gastrectomy Devices Market Company Profiles

  • 11.1. Intutive Surgical Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Apollo Endosurgery Inc.
  • 11.3. TransEnterix Inc.
  • 11.4. Cousin Biotech
  • 11.5. EnteroMedics Inc.
  • 11.6. Medtronics Plc.
  • 11.7. Medsinglong Co Ltd.
  • 11.8. Guangzhou Medunion Technologies Co.ltd
  • 11.9. Guangzhou Maya Medical Equipment.Co.ltd
  • 11.10. Agency for Medical Innovations (*LIST NOT EXHAUSTIVE)

12. Global Sleeve Gastrectomy Devices Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us